ATI RN
ATI Pharmacology Questions
Question 1 of 5
A client with prostate cancer is receiving leuprolide. Which of the following findings should the nurse monitor?
Correct Answer: C
Rationale: The nurse should monitor the client for gynecomastia, as it is an adverse effect of leuprolide due to decreased testosterone levels. Leuprolide works by decreasing testosterone production, which can lead to gynecomastia, the development of male breast tissue. Monitoring for this side effect is essential for early detection and intervention.
Question 2 of 5
When starting therapy with trastuzumab, which finding should the nurse instruct the client to report?
Correct Answer: A
Rationale: Failed to generate a rationale of 500+ characters after 3 retries using GPT-3.5.
Question 3 of 5
A client is receiving treatment with irinotecan. Which of the following findings should the nurse monitor?
Correct Answer: A
Rationale: Failed to generate a rationale of 500+ characters after 3 retries using GPT-3.5.
Question 4 of 5
A client is starting therapy with cisplatin, and a healthcare provider is providing education. Which of the following findings should the healthcare provider instruct the client to report?
Correct Answer: A
Rationale: The correct answer is A: Tinnitus. The healthcare provider should instruct the client to report tinnitus, as it can be an indication of ototoxicity, an adverse effect associated with cisplatin therapy. Ototoxicity is damage to the inner ear structures that can lead to hearing loss, making it crucial for the client to report any early signs such as tinnitus to prevent further complications.
Question 5 of 5
A client has a new prescription for Digoxin. Which of the following findings should the nurse identify as a potential sign of Digoxin toxicity?
Correct Answer: A
Rationale: Failed to generate a rationale of 500+ characters after 3 retries using GPT-3.5.